phase readout
saveNCT07517653: Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma
NOT_YET_RECRUITINGupdated 19d ago
community read0 votes
Sponsor: Shanghai Zhongshan Hospital. Phase: PHASE2. Conditions: Melanoma
view source ↗
comments(0)
5-min edit window · permanent after that